Its U.S formulations business saw a revenue growth of 57.4% to 24.54 billion rupees, while India formulations grew by 9.1% to 12.27 billion rupees. India and U.S. sales make up 38% and 48% of Zydus' total revenue, respectively.

August 08, 2023, witnessed a dynamic shift in the stock market as several prominent stocks demonstrated impressive market performance by crossing their 100 Simple Moving Averages (100 SMA).

The ace investor often called India's Warren Buffet, first invested in Concord in 2004 and later helped the company's founder in buying back the company from pharma major Mylan in 2009.

Plutus held 2.33 percent stake in Yatharth Hospital as per the shareholding data disclosed by the company last week.

Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023.

On the weekly front, the maximum Call OI is placed at 19600 and then towards 19,700 strikes while the maximum Put OI is placed at 19,400 and then towards 19,500 strikes.

Zydus Lifesciences has gained the US Food and Drug Administration's (FDA) approval to produce and market its Indomethacin suppositories. The drug is used to treat moderate to severe rheumatoid arthritis and acute flares of chronic disease, among other conditions. Zydus has been awarded 180-day CGT exclusivity to market the product after US authorities deemed there was a lack of competition.

The stock market witnessed notable movements as several stocks surged above their 20-day Simple Moving Average (SMA) on 1st August 2023, indicating bullish momentum. Investors are closely observing these stocks for potential investment opportunities in the market

5 counters crossed their 50-day Simple Moving Average (SMA) on July 27, 2023. Marico and Zydus Wellness take the lead, alongside other prominent companies like Havells India and TCI Express, showcasing positive market momentum and growth potential

Relative Strength Index (RSI) is a valuable technical indicator which gives insights to make informed decisions. It tells about stock's momentum and potential price movements. RSI measures the speed and change of price movements on a scale from 0 to 100, and readings above 70 indicate an overbought condition, while readings below 30 suggest an oversold condition. Analysing RSI trends can help investors gauge a stock's potential for price reversals or continued momentum.

Reports say the World Health Organization is set to classify aspartame as a possible carcinogen. India's FSSAI, which initially banned a natural alternative sugar, stevia in 2011, reversed the order later and gave it its nod. It now says that India may not necessarily follow the West's path on aspartame, as India is currently in a 'powerful' situation.

For FY23, the Glucon-D maker's standalone net profit stood at ₹66 crore, a 400 percent jump from the previous fiscal

Gautam S Adani and Rajesh S Adani, on behalf of SB Adani Family Trust, held 59.13 crore shares or 51.87 percent stake in the company as of March 2023

Mylab came into limelight during Covid pandemic when it developed and launched indigenous RT-PCR test kits and platform for diagnosing Covid.